Barrett's esophagus
ICD-10 K22.7 is a used to indicate a diagnosis of barrett's esophagus.
Barrett's esophagus is a condition characterized by the abnormal transformation of the squamous epithelium of the esophagus into a columnar epithelium, often as a consequence of chronic gastroesophageal reflux disease (GERD). Clinically, patients may present with symptoms such as heartburn, regurgitation, and difficulty swallowing. The condition primarily affects the lower esophagus, where the normal lining is replaced by intestinal-type cells, increasing the risk of esophageal adenocarcinoma. Disease progression can vary; while some patients remain asymptomatic, others may develop dysplasia, which is a precancerous change. Diagnosis is typically confirmed through endoscopy and biopsy, where the characteristic histological changes can be observed. Regular surveillance is recommended for patients diagnosed with Barrett's esophagus to monitor for dysplastic changes and potential progression to cancer.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K22.7 specifically covers Barrett's esophagus, which may include variations such as non-dysplastic Barrett's and Barrett's with dysplasia. It is important to document the presence of dysplasia as it may affect management and surveillance protocols.
K22.7 should be used when there is a confirmed diagnosis of Barrett's esophagus, particularly when there is evidence of intestinal metaplasia. It should not be used for general GERD symptoms without confirmation of Barrett's.
Documentation should include endoscopic findings, biopsy results confirming intestinal metaplasia, and any symptoms related to the condition. Surveillance intervals and management plans should also be documented.
